Bio-Rad Laboratories (BIO-B) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Bio-Rad Laboratories (BIO-B) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.49% |
| Dec 31, 2025 | -3.20% |
| Sep 30, 2025 | -17.71% |
| Jun 30, 2025 | -19.94% |
| Mar 31, 2025 | -37.77% |
| Dec 31, 2024 | -26.92% |
| Sep 30, 2024 | 35.24% |
| Jun 30, 2024 | -41.22% |
| Mar 31, 2024 | -15.00% |
| Dec 31, 2023 | 19.35% |
| Sep 30, 2023 | -16.97% |
| Jun 30, 2023 | -44.67% |
| Mar 31, 2023 | -36.29% |
| Dec 31, 2022 | 58.52% |
| Sep 30, 2022 | -56.47% |
| Jun 30, 2022 | -184.30% |
| Mar 31, 2022 | -207.36% |
| Dec 31, 2021 | -142.57% |
| Sep 30, 2021 | 196.64% |
| Jun 30, 2021 | 122.94% |